Streptomyces sp. Strain MBT28 Genome sequencing. Streptomyces sp. MBT28

This strain is a potentially rich source of new bio-active natural products that can be developed as resources for healthcare. Streptomycetes account for about 40% of all known natural products and typically contain over twenty bio-synthetic gene clusters that encode for known or predicted secondary metabolites.